Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Holm B et al. – ERCC1 expression is predictive for outcome in patients treated with carboplatin and gemcitabine. Patients with ERCC1–negative tumors had an increased survival compared to patients with ERCC1–positive tumors and this difference was mainly attributable to a survival difference among men.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address